Verdict No. 3047 · Search date 2026-09-08 · Methodology v1.0
Zintoma ginger capsules, 250 mg three times daily,
does it really help with Reduction of nausea severity in early pregnancy?
30-Second Summary
C
Evidence Grade C · 50 · Safety caution
This verdict is limited to nausea severity; vomiting, admission, and pregnancy outcomes are separate.
Caution. NCCIH says pregnancy use may be safe but advises clinician consultation; EMA retains precaution because product and dose data are limited. Reflux, abdominal discomfort, diarrhea, and medicine interactions require review.
What the
research showsGrade C with 50 points. Early-pregnancy placebo trials and syntheses suggest less nausea, but prespecification of nausea alone, an exact between-group estimate, and product-specific independent replication remain insufficient. Vomiting and pregnancy safety were not substituted for this outcome.
research showsGrade C with 50 points. Early-pregnancy placebo trials and syntheses suggest less nausea, but prespecification of nausea alone, an exact between-group estimate, and product-specific independent replication remain insufficient. Vomiting and pregnancy safety were not substituted for this outcome.
What the
ads claimThis cannot be extended to replacing treatment for hyperemesis, preventing vomiting or admission, or every ginger food product.
ads claimThis cannot be extended to replacing treatment for hyperemesis, preventing vomiting or admission, or every ginger food product.
Useful facts when choosing a product
- This verdict applies only to the exact formulation, route, dose, duration, population, endpoint, and comparator shown above.
- Ginger food, powder, standardized extract, essential oil, topical products, and combination products are not interchangeable.
- Caution. NCCIH says pregnancy use may be safe but advises clinician consultation; EMA retains precaution because product and dose data are limited. Reflux, abdominal discomfort, diarrhea, and medicine interactions require review.
Chamgap Semantic Classification Code
Permanent code issued
S.ginger.oral.pregnancy-nausea-severity.reduce.placeboSupplements and nutraceuticals > Ginger > Oral > Pregnancy nausea severity > Reduction claim > Placebo
Issued for early-pregnancy nausea severity; vomiting, admission, and pregnancy outcomes are separate. The code identifies the intervention and claim; it never contains the evidence grade, score, or safety result.
Exact Claim Classification
These independent facets prevent evidence from different forms, routes, populations, effects, and comparators from being mixed.
| Intervention class | S · Supplement or nutraceutical |
|---|---|
| Canonical ingredient or intervention | Ginger |
| Source or part used | Rhizome of Zingiber officinale Roscoe |
| Formulation or processing | Zintoma 250-mg capsules; gingerol/shogaol assay and extraction unverified |
| Route | Oral |
| Dose | 250 mg three times daily, 750 mg/day |
| Duration | Four days |
| Population | Singleton pregnancy before 16 weeks with mild-to-moderate nausea/vomiting |
| Effect or condition | Nausea-severity reduction |
| Primary endpoint | Change in the Rhodes nausea subscore |
| Comparator | Matching lactose capsules with the same dietary advice |
| Duplicate-detection key | ginger|Zintoma-250mg-capsules|oral|singleton-pregnancy-under-16-weeks-mild-moderate-nausea|nausea-severity-reduction|4-days |
Gap Measurement · Verdict 3047 · C 50
What the research actually shows
RCT meta-analyses versus placebo or vitamin B6 were checked against a 2024 pregnancy evidence scan and ACOG, NCCIH, and EMA safety sources.
Why this is classified as C (50)
Independent academic funding is a strength, but endpoint prespecification, the exact contrast, product-specific replication, and precision remain unresolved, with small and short trials; the result is C with 50 points.
Counterpoint. The pooled vomiting-frequency result was null, and formulation, dose, scale, and trial quality varied.
Rejudgment record. Independent Codex cross-check — One formulation, one route, one population, one claim, one principal endpoint and comparator
Scoring profile behind this grade
| Endpoint | P | Patient-reported treatment goal - the symptom is the goal |
| Replication | R1 | Single confirmatory trial |
| Independence | I2 | Decisive evidence is publicly or non-profit funded |
| Effect size | EX | The clinical size of the effect could not be judged |
| Precision | CX | No pooled confidence interval could be confirmed |
The scoring table and the verdict agree (C).
Cross-check — AI research and Codex final gate
AI was used for research and drafting. Blind grading, adversarial audit, and the methodology boundary rules were then reapplied before Codex performed the final evidence, grade, copy, and build checks. If a grade cannot be narrowed, both evidence positions and their reasons are published.
Evidence Table
| Study | Design | Sample | Funding | Endpoint | Result | Weight |
|---|---|---|---|---|---|---|
| Effect of Ginger on Relieving Nausea and Vomiting in Pregnancy: A Randomized, Placebo-Controlled Trial | The cited design, allocation, masking, endpoint hierarchy, and analysis limitations were independently checked. | 73 | Funding, product support, employee authorship, and declared conflicts were assessed separately. | The principal endpoint contract is preserved; secondary outcomes remain separate. | Verified estimates are preserved; missing confidence intervals or event counts were not invented. | Evidence weight reflects directness, formulation match, endpoint hierarchy, and reporting limitations. |
| Effect of ginger in the treatment of nausea and vomiting compared with vitamin B6 and placebo during pregnancy: a meta-analysis | The cited design, allocation, masking, endpoint hierarchy, and analysis limitations were independently checked. | 1,174 | Funding, product support, employee authorship, and declared conflicts were assessed separately. | The principal endpoint contract is preserved; secondary outcomes remain separate. | Verified estimates are preserved; missing confidence intervals or event counts were not invented. | Evidence weight reflects directness, formulation match, endpoint hierarchy, and reporting limitations. |
Receipt — 2 References
All 2 cited sources were verified for existence at the original page (as of 2026-09-08).
Saberi F et al. Nurs Midwifery Stud. 2014. PMID: 25414888. PMCID: PMC4228518. DOI: 10.17795/nmsjournal11841. IRCT201103192699N4.
checkedHu Y et al. J Matern Fetal Neonatal Med. 2022;35:187-196. PMID: 31937153. DOI: 10.1080/14767058.2020.1712714.
checkedResearch and draft: AI used · Cross-check: blind grading and adversarial audit
Final verification and publication gate: Codex · Verification cutoff: 2026-09-08 · Corrections: none
Final verification and publication gate: Codex · Verification cutoff: 2026-09-08 · Corrections: none
Cite this verdict
[Chamgap] Ginger for Nausea in Early Pregnancy—Severity Fell Versus Placebo, but Vomiting and Long-Term Safety Are Separate — Evidence Grade C·50. 2 cited sources checked. Source: https://chamgap.com/en/verdicts/womens/oral-ginger-early-pregnancy-nausea-severity/ · CC BY 4.0CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.
What this document does and does not do
Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.